(Total Views: 121)
Posted On: 12/01/2022 8:05:51 AM
Post# of 110161
$CGEN News Article - Compugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Anti-Tumor Activity and Immune Activation in Platinum Resistant Ovarian Cancer Patients https://marketwirenews.com/news-releases/comp...91071.html
(0)
(0)
My Twitter: WhyteStocks
